Alnylam Pharmaceuticals, Inc. Savings & Investment Plan — Form 5500 plan (Alnylam Pharmaceuticals, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a benefit plan reported by Alnylam Pharmaceuticals, Inc. under EIN 04-3696884 and plan number 001. The latest loaded filing year is 2023. The filing reports 2,090 participants and $275,616,093 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Alnylam Pharmaceuticals, Inc.
EIN
04-3696884
Plan number
001
Plan type
2
Location
Cambridge, MA
Latest filing year
2023
Participants
2,090
End-of-year plan assets
$275,616,093

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20232,090H, C20241010083758NAL0020698641001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$275,616,093
Total liabilities (EOY)
$0
Net assets (EOY)
$275,616,093
Net assets (BOY)
$210,168,343

Income & contributions

Employer contributions
$11,168,448
Participant contributions
$27,886,695
Total contributions
$48,057,270
Total income / additions
$80,849,506

Expenses & distributions

Benefits paid
$15,182,936
Administrative expenses
$180,647
Total expenses
$15,401,756
Net increase / (decrease)
$65,447,750

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Merrill Lynch Pierce Fenner & SmitINVESTMENT ADVISOR$106,250not reported in the loaded dataset2023
Fidelity Investments InstitutionalRECORDKEEPER$43,498$02023
Rsm Us LlpACCOUNTANT/AUDITOR$30,896not reported in the loaded dataset2023

Related Form 5500 pages